PATHOBIOTEK DIAGNOSTICS INC/TX
10QSB, EX-27, 2000-08-14
NON-OPERATING ESTABLISHMENTS
Previous: PATHOBIOTEK DIAGNOSTICS INC/TX, 10QSB, 2000-08-14
Next: UNITED VENTURES GROUP INC /CO/, 10QSB, 2000-08-14



<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-END>                                   JUN-30-2000
<CASH>                                         0
<SECURITIES>                                   0
<RECEIVABLES>                                  2158
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               2158
<PP&E>                                         140,339
<DEPRECIATION>                                 (79,988)
<TOTAL-ASSETS>                                 113,942
<CURRENT-LIABILITIES>                          1,462,899
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       13,852
<OTHER-SE>                                     (1,362,809)
<TOTAL-LIABILITY-AND-EQUITY>                   113,942
<SALES>                                        0
<TOTAL-REVENUES>                               0
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               507,412
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             2074
<INCOME-PRETAX>                                (509,486)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            0
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (509,486)
<EPS-BASIC>                                    (0.04)
<EPS-DILUTED>                                  (0.04)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission